# A Randomised Trial of Chemotherapy Plus Surgery for Recurrent Non-Small Cell Lung Cancer

> **NCT02889666** · PHASE1 · RECRUITING · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 500 (estimated)

## Conditions studied

- Recurrent Non-small Cell Lung Cancer

## Interventions

- **DRUG:** Cisplatin
- **DRUG:** Carboplatin
- **DRUG:** Docetaxel
- **DRUG:** Gemcitabine/Carboplatin
- **DRUG:** Gemcitabine/Cisplatin
- **DRUG:** Docetaxel/Oxaliplatin
- **DRUG:** Docetaxel/Carboplatin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02889666
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2008-01
- **Primary completion:** 2026-12
- **Final completion:** 2027-12
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2024-04-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02889666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02889666, "A Randomised Trial of Chemotherapy Plus Surgery for Recurrent Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02889666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*